TRIMTECH Therapeutics
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
$47MSeed+
Role not disclosedActivity from announced rounds
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
Develops AI-driven control software for energy-intensive industries
Pitching Cambridge Enterprise Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room